Prostate Cancer Screening IMPACT ECHO
January 2024 - December 2024
Prostate Cancer is the 2nd leading cause of cancer death in U.S. men with a 4-5% annual increase of advanced-stage diagnosis. Shared decision-making and appropriate PSA testing is imperative for the improvement prostate cancer outcomes for all men, especially for Black men who carry a disproportionate burden of occurrences and deaths in the U.S. The intended audience for this ECHO program is teams from FQHCs/other safety-net primary care clinics. This program has eight monthly, hour-long sessions running February through September of 2024.
This ECHO is part of our IMPACT Initiative – Improving Mortality from Prostate Cancer Together.